Antidiuretic Drugs Market Application Information:
By Type (Vasopressin, Desmopressin, Oxytocin, others), By Indication (Diabetes
Insipidus, Hemophilia, Hypertension, others), By End Users (Hospitals, Clinics,
Pharmaceutical Companies, others) - Global Forecast till 2023
Market
Highlights
The
Global Antidiuretic Drugs Market Application is expected to show sharp growth over the forecast
period. Increasing prevalence of diabetes and demand for new drugs for its
treatment are the key factor for the market growth. Rising geriatric population
with diabetes insipidus also drive the market growth. Also, use of antidiuretic
drugs for the treatment of hypertension is found to be increasing across the
globe.
The
Global Antidiuretic Drugs Market Application is expected to grow at a CAGR of
9.7% during the forecast period and is estimated to reach USD 180 million by
2023.
Taste the
Market data and market information presented through more than 120 market data
tables and figures spread over 200 pages of the project report. Avail the
in-depth table of content TOC & market synopsis on “Antidiuretic Drugs
Market Application research report–Global forecast till 2023.”
Major
Players in Antidiuretic Drugs Market Application
Some of
the key players in the global market are Par Sterile Products, LLC (U.S.),
ADH Health (U.S.), Azevan Pharmaceuticals, Inc. (U.S.), Teva Pharmaceutical
Industries Ltd. (Israel), Otsuka Holdings Co. Ltd (Japan), Taj Pharmaceuticals
Limited (India) and ALLERGAN (U.S.).
Browse Complete Report: https://www.marketresearchfuture.com/reports/antidiuretic-drugs-market-4306
Regional Analysis
The global Antidiuretic Drugs Market Application consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.
The global Antidiuretic Drugs Market Application consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas dominate the global Antidiuretic Drugs Market
Application. It comprises of two regions namely North America and South
America. The market in the American region is driven by the rising prevalence
of diabetes insipidus. Increase in geriatric population with diabetes and
hypertension also contribute to the market growth.
In Europe, increasing adoption of new drugs for the treatment of
diabetes insipidus, and availability of funds for research and development.
Asia Pacific is the fastest growing and potential market for the
antidiuretic drugs treatment, whose growth is attributed to the increase in the
awareness about the use of antidiuretics for the treatment and its side
effects. Expansion of healthcare system in developing countries in Asia Pacific
also favors the market growth.
The Middle East & Africa is expected to witness steady growth
due to rising demand for primary healthcare services.
Segmentation
The global Antidiuretic Drugs Market Application is segmented on the basis of types, which includes vasopressin, desmopressin, oxytocin, and others. Other types of antidiuretic drugs are argipressin, lypressin, ornipressin and terlipressin. On the basis of indication, the market is segmented into diabetes insipidus, hemophilia, hypertension, and others. Diabetes insipidus is further sub-segmented into central diabetes insipidus, nephrogenic diabetes insipidus, dipsogenic diabetes insipidus and gestational diabetes insipidus. Other indications are polyuria, polydipsia and enuresis. On the basis of end users, the market is segmented into hospitals, clinics, pharmaceutical companies, and others.
The global Antidiuretic Drugs Market Application is segmented on the basis of types, which includes vasopressin, desmopressin, oxytocin, and others. Other types of antidiuretic drugs are argipressin, lypressin, ornipressin and terlipressin. On the basis of indication, the market is segmented into diabetes insipidus, hemophilia, hypertension, and others. Diabetes insipidus is further sub-segmented into central diabetes insipidus, nephrogenic diabetes insipidus, dipsogenic diabetes insipidus and gestational diabetes insipidus. Other indications are polyuria, polydipsia and enuresis. On the basis of end users, the market is segmented into hospitals, clinics, pharmaceutical companies, and others.
No comments:
Post a Comment